nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—ABCC2—Lamivudine—hepatitis B	0.427	1	CbGbCtD
Olmesartan—ABCC2—bile duct—hepatitis B	0.045	0.442	CbGeAlD
Olmesartan—AGTR1—blood plasma—hepatitis B	0.0136	0.134	CbGeAlD
Olmesartan—SLCO1B1—blood plasma—hepatitis B	0.0129	0.127	CbGeAlD
Olmesartan—Transaminases increased—Entecavir—hepatitis B	0.0103	0.0219	CcSEcCtD
Olmesartan—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00976	0.0208	CcSEcCtD
Olmesartan—Glycosuria—Entecavir—hepatitis B	0.00771	0.0164	CcSEcCtD
Olmesartan—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0076	0.0162	CcSEcCtD
Olmesartan—Laryngeal pain—Telbivudine—hepatitis B	0.00753	0.016	CcSEcCtD
Olmesartan—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00752	0.016	CcSEcCtD
Olmesartan—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00746	0.0159	CcSEcCtD
Olmesartan—Influenza-like symptoms—Telbivudine—hepatitis B	0.00718	0.0153	CcSEcCtD
Olmesartan—SLCO1B3—liver—hepatitis B	0.00641	0.0631	CbGeAlD
Olmesartan—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00636	0.0135	CcSEcCtD
Olmesartan—Rhinorrhoea—Telbivudine—hepatitis B	0.00633	0.0135	CcSEcCtD
Olmesartan—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00599	0.0128	CcSEcCtD
Olmesartan—Rhabdomyolysis—Telbivudine—hepatitis B	0.0058	0.0124	CcSEcCtD
Olmesartan—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.0055	0.0117	CcSEcCtD
Olmesartan—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00503	0.0107	CcSEcCtD
Olmesartan—Influenza like illness—Telbivudine—hepatitis B	0.00498	0.0106	CcSEcCtD
Olmesartan—AGTR1—blood—hepatitis B	0.00497	0.049	CbGeAlD
Olmesartan—SLCO1B1—blood—hepatitis B	0.00474	0.0467	CbGeAlD
Olmesartan—Blood triglycerides increased—Lamivudine—hepatitis B	0.00441	0.0094	CcSEcCtD
Olmesartan—Bone marrow depression—Lamivudine—hepatitis B	0.00428	0.00912	CcSEcCtD
Olmesartan—Blood creatinine increased—Entecavir—hepatitis B	0.00425	0.00905	CcSEcCtD
Olmesartan—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.0042	0.00895	CcSEcCtD
Olmesartan—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00414	0.00883	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0039	0.00831	CcSEcCtD
Olmesartan—AGTR1—liver—hepatitis B	0.00389	0.0383	CbGeAlD
Olmesartan—Pancreatitis—Entecavir—hepatitis B	0.00384	0.00818	CcSEcCtD
Olmesartan—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00375	0.00798	CcSEcCtD
Olmesartan—Pain in extremity—Telbivudine—hepatitis B	0.00372	0.00793	CcSEcCtD
Olmesartan—SLCO1B1—liver—hepatitis B	0.00371	0.0365	CbGeAlD
Olmesartan—Neutropenia—Entecavir—hepatitis B	0.00366	0.0078	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Entecavir—hepatitis B	0.00364	0.00776	CcSEcCtD
Olmesartan—ABCC2—blood—hepatitis B	0.0036	0.0354	CbGeAlD
Olmesartan—Rhinorrhoea—Lamivudine—hepatitis B	0.00357	0.0076	CcSEcCtD
Olmesartan—Hyperglycaemia—Entecavir—hepatitis B	0.00353	0.00753	CcSEcCtD
Olmesartan—Renal failure—Entecavir—hepatitis B	0.00343	0.00732	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00335	0.00714	CcSEcCtD
Olmesartan—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00335	0.00714	CcSEcCtD
Olmesartan—Haematuria—Entecavir—hepatitis B	0.00333	0.0071	CcSEcCtD
Olmesartan—Nasopharyngitis—Telbivudine—hepatitis B	0.00333	0.00709	CcSEcCtD
Olmesartan—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00332	0.00708	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00328	0.007	CcSEcCtD
Olmesartan—Rhabdomyolysis—Lamivudine—hepatitis B	0.00327	0.00696	CcSEcCtD
Olmesartan—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00325	0.00692	CcSEcCtD
Olmesartan—Influenza—Telbivudine—hepatitis B	0.00322	0.00686	CcSEcCtD
Olmesartan—Viral infection—Lamivudine—hepatitis B	0.0032	0.00682	CcSEcCtD
Olmesartan—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0032	0.00681	CcSEcCtD
Olmesartan—Oedema peripheral—Entecavir—hepatitis B	0.00309	0.00658	CcSEcCtD
Olmesartan—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00306	0.00651	CcSEcCtD
Olmesartan—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00304	0.00647	CcSEcCtD
Olmesartan—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00302	0.00644	CcSEcCtD
Olmesartan—Neutropenia—Telbivudine—hepatitis B	0.00301	0.00641	CcSEcCtD
Olmesartan—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00301	0.00641	CcSEcCtD
Olmesartan—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.003	0.00639	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00299	0.00637	CcSEcCtD
Olmesartan—Vasculitis—Lamivudine—hepatitis B	0.00296	0.00631	CcSEcCtD
Olmesartan—Renal failure—Telbivudine—hepatitis B	0.00282	0.00601	CcSEcCtD
Olmesartan—ABCC2—liver—hepatitis B	0.00281	0.0277	CbGeAlD
Olmesartan—Alopecia—Entecavir—hepatitis B	0.00277	0.0059	CcSEcCtD
Olmesartan—Mental disorder—Entecavir—hepatitis B	0.00275	0.00585	CcSEcCtD
Olmesartan—Malnutrition—Entecavir—hepatitis B	0.00273	0.00582	CcSEcCtD
Olmesartan—Aplastic anaemia—Lamivudine—hepatitis B	0.00271	0.00578	CcSEcCtD
Olmesartan—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00266	0.00567	CcSEcCtD
Olmesartan—Back pain—Adefovir Dipivoxil—hepatitis B	0.00258	0.00549	CcSEcCtD
Olmesartan—Pharyngitis—Telbivudine—hepatitis B	0.00256	0.00545	CcSEcCtD
Olmesartan—Connective tissue disorder—Telbivudine—hepatitis B	0.00253	0.00539	CcSEcCtD
Olmesartan—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00246	0.00524	CcSEcCtD
Olmesartan—Leukopenia—Entecavir—hepatitis B	0.00244	0.00521	CcSEcCtD
Olmesartan—Sleep disorder—Lamivudine—hepatitis B	0.00242	0.00516	CcSEcCtD
Olmesartan—Gastroenteritis—Lamivudine—hepatitis B	0.00237	0.00504	CcSEcCtD
Olmesartan—Cough—Adefovir Dipivoxil—hepatitis B	0.00232	0.00495	CcSEcCtD
Olmesartan—Mediastinal disorder—Telbivudine—hepatitis B	0.00232	0.00495	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00231	0.00492	CcSEcCtD
Olmesartan—Injury—Lamivudine—hepatitis B	0.00228	0.00486	CcSEcCtD
Olmesartan—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00227	0.00483	CcSEcCtD
Olmesartan—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00227	0.00483	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00225	0.0048	CcSEcCtD
Olmesartan—Malnutrition—Telbivudine—hepatitis B	0.00224	0.00478	CcSEcCtD
Olmesartan—Anaphylactic shock—Entecavir—hepatitis B	0.00223	0.00475	CcSEcCtD
Olmesartan—Infection—Entecavir—hepatitis B	0.00221	0.00472	CcSEcCtD
Olmesartan—Nervous system disorder—Entecavir—hepatitis B	0.00219	0.00465	CcSEcCtD
Olmesartan—Back pain—Telbivudine—hepatitis B	0.00217	0.00462	CcSEcCtD
Olmesartan—Skin disorder—Entecavir—hepatitis B	0.00216	0.00461	CcSEcCtD
Olmesartan—Muscle spasms—Telbivudine—hepatitis B	0.00216	0.00459	CcSEcCtD
Olmesartan—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00213	0.00454	CcSEcCtD
Olmesartan—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00213	0.00453	CcSEcCtD
Olmesartan—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00211	0.0045	CcSEcCtD
Olmesartan—Ill-defined disorder—Telbivudine—hepatitis B	0.00208	0.00443	CcSEcCtD
Olmesartan—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00207	0.00441	CcSEcCtD
Olmesartan—Malaise—Telbivudine—hepatitis B	0.00202	0.00431	CcSEcCtD
Olmesartan—Insomnia—Entecavir—hepatitis B	0.00202	0.00429	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00198	0.00422	CcSEcCtD
Olmesartan—Dyspepsia—Entecavir—hepatitis B	0.00196	0.00418	CcSEcCtD
Olmesartan—Cough—Telbivudine—hepatitis B	0.00196	0.00417	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Entecavir—hepatitis B	0.00192	0.0041	CcSEcCtD
Olmesartan—Fatigue—Entecavir—hepatitis B	0.00192	0.00409	CcSEcCtD
Olmesartan—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00191	0.00408	CcSEcCtD
Olmesartan—Myalgia—Telbivudine—hepatitis B	0.00191	0.00407	CcSEcCtD
Olmesartan—Arthralgia—Telbivudine—hepatitis B	0.00191	0.00407	CcSEcCtD
Olmesartan—Chest pain—Telbivudine—hepatitis B	0.00191	0.00407	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0019	0.00404	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00189	0.00403	CcSEcCtD
Olmesartan—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00189	0.00403	CcSEcCtD
Olmesartan—Discomfort—Telbivudine—hepatitis B	0.00189	0.00402	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00188	0.004	CcSEcCtD
Olmesartan—Nasopharyngitis—Lamivudine—hepatitis B	0.00188	0.004	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00185	0.00394	CcSEcCtD
Olmesartan—Gastrointestinal pain—Entecavir—hepatitis B	0.00182	0.00388	CcSEcCtD
Olmesartan—Influenza—Lamivudine—hepatitis B	0.00181	0.00386	CcSEcCtD
Olmesartan—Nervous system disorder—Telbivudine—hepatitis B	0.0018	0.00382	CcSEcCtD
Olmesartan—Thrombocytopenia—Telbivudine—hepatitis B	0.00179	0.00382	CcSEcCtD
Olmesartan—Pancreatitis—Lamivudine—hepatitis B	0.00178	0.00379	CcSEcCtD
Olmesartan—Skin disorder—Telbivudine—hepatitis B	0.00178	0.00379	CcSEcCtD
Olmesartan—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00178	0.00379	CcSEcCtD
Olmesartan—Body temperature increased—Entecavir—hepatitis B	0.00176	0.00375	CcSEcCtD
Olmesartan—Abdominal pain—Entecavir—hepatitis B	0.00176	0.00375	CcSEcCtD
Olmesartan—Bronchitis—Lamivudine—hepatitis B	0.00174	0.00372	CcSEcCtD
Olmesartan—Pancytopenia—Lamivudine—hepatitis B	0.00172	0.00367	CcSEcCtD
Olmesartan—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00172	0.00366	CcSEcCtD
Olmesartan—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00172	0.00366	CcSEcCtD
Olmesartan—Neutropenia—Lamivudine—hepatitis B	0.0017	0.00361	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00167	0.00355	CcSEcCtD
Olmesartan—Insomnia—Telbivudine—hepatitis B	0.00166	0.00353	CcSEcCtD
Olmesartan—Hyperglycaemia—Lamivudine—hepatitis B	0.00164	0.00349	CcSEcCtD
Olmesartan—Dyspepsia—Telbivudine—hepatitis B	0.00161	0.00343	CcSEcCtD
Olmesartan—Asthenia—Entecavir—hepatitis B	0.0016	0.00341	CcSEcCtD
Olmesartan—Renal failure—Lamivudine—hepatitis B	0.00159	0.00339	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00158	0.00337	CcSEcCtD
Olmesartan—Fatigue—Telbivudine—hepatitis B	0.00158	0.00336	CcSEcCtD
Olmesartan—Jaundice—Lamivudine—hepatitis B	0.00158	0.00336	CcSEcCtD
Olmesartan—Pain—Telbivudine—hepatitis B	0.00157	0.00333	CcSEcCtD
Olmesartan—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00156	0.00332	CcSEcCtD
Olmesartan—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00154	0.00328	CcSEcCtD
Olmesartan—Diarrhoea—Entecavir—hepatitis B	0.00152	0.00325	CcSEcCtD
Olmesartan—Sinusitis—Lamivudine—hepatitis B	0.00152	0.00323	CcSEcCtD
Olmesartan—Agranulocytosis—Lamivudine—hepatitis B	0.00151	0.00322	CcSEcCtD
Olmesartan—Feeling abnormal—Telbivudine—hepatitis B	0.00151	0.00321	CcSEcCtD
Olmesartan—Gastrointestinal pain—Telbivudine—hepatitis B	0.0015	0.00319	CcSEcCtD
Olmesartan—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00149	0.00317	CcSEcCtD
Olmesartan—Dizziness—Entecavir—hepatitis B	0.00147	0.00314	CcSEcCtD
Olmesartan—Rhinitis—Lamivudine—hepatitis B	0.00146	0.0031	CcSEcCtD
Olmesartan—Body temperature increased—Telbivudine—hepatitis B	0.00145	0.00308	CcSEcCtD
Olmesartan—Abdominal pain—Telbivudine—hepatitis B	0.00145	0.00308	CcSEcCtD
Olmesartan—Pharyngitis—Lamivudine—hepatitis B	0.00144	0.00307	CcSEcCtD
Olmesartan—Connective tissue disorder—Lamivudine—hepatitis B	0.00143	0.00304	CcSEcCtD
Olmesartan—Vomiting—Entecavir—hepatitis B	0.00142	0.00302	CcSEcCtD
Olmesartan—Rash—Entecavir—hepatitis B	0.0014	0.00299	CcSEcCtD
Olmesartan—Dermatitis—Entecavir—hepatitis B	0.0014	0.00299	CcSEcCtD
Olmesartan—Headache—Entecavir—hepatitis B	0.0014	0.00297	CcSEcCtD
Olmesartan—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00138	0.00294	CcSEcCtD
Olmesartan—Rash—Adefovir Dipivoxil—hepatitis B	0.00137	0.00292	CcSEcCtD
Olmesartan—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00137	0.00292	CcSEcCtD
Olmesartan—Headache—Adefovir Dipivoxil—hepatitis B	0.00136	0.0029	CcSEcCtD
Olmesartan—Nausea—Entecavir—hepatitis B	0.00132	0.00282	CcSEcCtD
Olmesartan—Asthenia—Telbivudine—hepatitis B	0.00131	0.0028	CcSEcCtD
Olmesartan—Mediastinal disorder—Lamivudine—hepatitis B	0.00131	0.00279	CcSEcCtD
Olmesartan—Pruritus—Telbivudine—hepatitis B	0.0013	0.00276	CcSEcCtD
Olmesartan—Nausea—Adefovir Dipivoxil—hepatitis B	0.00129	0.00275	CcSEcCtD
Olmesartan—Alopecia—Lamivudine—hepatitis B	0.00128	0.00273	CcSEcCtD
Olmesartan—Malnutrition—Lamivudine—hepatitis B	0.00126	0.00269	CcSEcCtD
Olmesartan—Diarrhoea—Telbivudine—hepatitis B	0.00125	0.00267	CcSEcCtD
Olmesartan—Back pain—Lamivudine—hepatitis B	0.00122	0.0026	CcSEcCtD
Olmesartan—Muscle spasms—Lamivudine—hepatitis B	0.00122	0.00259	CcSEcCtD
Olmesartan—Dizziness—Telbivudine—hepatitis B	0.00121	0.00258	CcSEcCtD
Olmesartan—Ill-defined disorder—Lamivudine—hepatitis B	0.00117	0.0025	CcSEcCtD
Olmesartan—Anaemia—Lamivudine—hepatitis B	0.00117	0.00249	CcSEcCtD
Olmesartan—Vomiting—Telbivudine—hepatitis B	0.00116	0.00248	CcSEcCtD
Olmesartan—Angioedema—Lamivudine—hepatitis B	0.00115	0.00246	CcSEcCtD
Olmesartan—Rash—Telbivudine—hepatitis B	0.00115	0.00246	CcSEcCtD
Olmesartan—Dermatitis—Telbivudine—hepatitis B	0.00115	0.00246	CcSEcCtD
Olmesartan—Headache—Telbivudine—hepatitis B	0.00115	0.00244	CcSEcCtD
Olmesartan—Malaise—Lamivudine—hepatitis B	0.00114	0.00243	CcSEcCtD
Olmesartan—Vertigo—Lamivudine—hepatitis B	0.00114	0.00242	CcSEcCtD
Olmesartan—Syncope—Lamivudine—hepatitis B	0.00113	0.00241	CcSEcCtD
Olmesartan—Leukopenia—Lamivudine—hepatitis B	0.00113	0.00241	CcSEcCtD
Olmesartan—Loss of consciousness—Lamivudine—hepatitis B	0.00111	0.00237	CcSEcCtD
Olmesartan—Cough—Lamivudine—hepatitis B	0.0011	0.00235	CcSEcCtD
Olmesartan—Nausea—Telbivudine—hepatitis B	0.00109	0.00232	CcSEcCtD
Olmesartan—Arthralgia—Lamivudine—hepatitis B	0.00108	0.00229	CcSEcCtD
Olmesartan—Chest pain—Lamivudine—hepatitis B	0.00108	0.00229	CcSEcCtD
Olmesartan—Myalgia—Lamivudine—hepatitis B	0.00108	0.00229	CcSEcCtD
Olmesartan—Anxiety—Lamivudine—hepatitis B	0.00107	0.00228	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00107	0.00228	CcSEcCtD
Olmesartan—Discomfort—Lamivudine—hepatitis B	0.00106	0.00226	CcSEcCtD
Olmesartan—Oedema—Lamivudine—hepatitis B	0.00103	0.0022	CcSEcCtD
Olmesartan—Anaphylactic shock—Lamivudine—hepatitis B	0.00103	0.0022	CcSEcCtD
Olmesartan—Infection—Lamivudine—hepatitis B	0.00102	0.00218	CcSEcCtD
Olmesartan—Valsartan—ALB—hepatitis B	0.00102	0.672	CrCbGaD
Olmesartan—Shock—Lamivudine—hepatitis B	0.00101	0.00216	CcSEcCtD
Olmesartan—Nervous system disorder—Lamivudine—hepatitis B	0.00101	0.00215	CcSEcCtD
Olmesartan—Thrombocytopenia—Lamivudine—hepatitis B	0.00101	0.00215	CcSEcCtD
Olmesartan—Skin disorder—Lamivudine—hepatitis B	0.001	0.00213	CcSEcCtD
Olmesartan—Hyperhidrosis—Lamivudine—hepatitis B	0.000997	0.00212	CcSEcCtD
Olmesartan—Anorexia—Lamivudine—hepatitis B	0.000983	0.00209	CcSEcCtD
Olmesartan—Hypotension—Lamivudine—hepatitis B	0.000964	0.00205	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00094	0.002	CcSEcCtD
Olmesartan—Insomnia—Lamivudine—hepatitis B	0.000933	0.00199	CcSEcCtD
Olmesartan—Dyspepsia—Lamivudine—hepatitis B	0.000908	0.00193	CcSEcCtD
Olmesartan—Decreased appetite—Lamivudine—hepatitis B	0.000897	0.00191	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000891	0.0019	CcSEcCtD
Olmesartan—Fatigue—Lamivudine—hepatitis B	0.000889	0.00189	CcSEcCtD
Olmesartan—Constipation—Lamivudine—hepatitis B	0.000882	0.00188	CcSEcCtD
Olmesartan—Pain—Lamivudine—hepatitis B	0.000882	0.00188	CcSEcCtD
Olmesartan—Feeling abnormal—Lamivudine—hepatitis B	0.00085	0.00181	CcSEcCtD
Olmesartan—Gastrointestinal pain—Lamivudine—hepatitis B	0.000844	0.0018	CcSEcCtD
Olmesartan—Urticaria—Lamivudine—hepatitis B	0.00082	0.00175	CcSEcCtD
Olmesartan—Abdominal pain—Lamivudine—hepatitis B	0.000815	0.00174	CcSEcCtD
Olmesartan—Body temperature increased—Lamivudine—hepatitis B	0.000815	0.00174	CcSEcCtD
Olmesartan—Asthenia—Lamivudine—hepatitis B	0.00074	0.00158	CcSEcCtD
Olmesartan—Pruritus—Lamivudine—hepatitis B	0.00073	0.00155	CcSEcCtD
Olmesartan—Diarrhoea—Lamivudine—hepatitis B	0.000706	0.0015	CcSEcCtD
Olmesartan—Dizziness—Lamivudine—hepatitis B	0.000682	0.00145	CcSEcCtD
Olmesartan—Vomiting—Lamivudine—hepatitis B	0.000656	0.0014	CcSEcCtD
Olmesartan—Rash—Lamivudine—hepatitis B	0.00065	0.00139	CcSEcCtD
Olmesartan—Dermatitis—Lamivudine—hepatitis B	0.00065	0.00138	CcSEcCtD
Olmesartan—Headache—Lamivudine—hepatitis B	0.000646	0.00138	CcSEcCtD
Olmesartan—Nausea—Lamivudine—hepatitis B	0.000613	0.00131	CcSEcCtD
Olmesartan—Losartan—ALB—hepatitis B	0.0005	0.328	CrCbGaD
